Cooperation with healthcare professionals

As an innovation-oriented biotech company, Roche is committed to the research, development and manufacture of new medicines and diagnostic tests which help patients to lead longer and better lives. To make these medical advances available to patients as quickly as possible, we collaborate on a range of activities from clinical research, sharing best clinical practice and exchanging information on how new medicines fit into the patient pathway. This plays a big part in informing Roche’s efforts to improve patient care and treatment options – and is essential in improving health outcomes.

Roche fully supports efforts to improve the understanding of the relationship between the pharmaceutical industry and healthcare organisations and healthcare professionals among patients, the media and other stakeholders.

Each year, across Europe Roche, and members of the Roche group (and) discloses payments and other transfers of value in line with the European Federation of Pharmaceutical Industries and Associationsand its local transpositions. The(PDF 0.5 MB) signed by the CEO of Pharma and Head of Pharma International, confirms the application of the principles of the EFPIA Disclosure Code. The letter from the previous year is available

Reports

Europe Patient Reports

Patient organisations are also important partners for Roche in helping patients and their families to cope with a disease. To understand how Roche Collaborates with Patient Organisations see

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.

Accessibility statement